Table 4.
The proportion of children refilling their initial anti-anxiety medication class and continuing that medication class for six months
| Initial medication classa | Total No. |
Refilled initial prescriptionb % (95% CI) |
Continued medication for 6 months % (95% CI) |
|---|---|---|---|
| SSRI | 58,872 | 81 (80–81) | 55 (55–56) |
| Benzodiazepine | 10,005 | 25 (24–26) | 5 (4–7) |
| Hydroxyzine | 4,165 | 19 (18–20) | 3 (1–7) |
| Other antidepressant | 4,151 | 58 (56–59) | 28 (26–31) |
| Atypical antipsychotic | 3,501 | 71 (69–72) | 41 (38–43) |
| Other anti-anxietyc | 3,424 | 64 (62–66) | 38 (35–40) |
| Buspirone | 1,474 | 49 (46–51) | 19 (15–23) |
| Bupropion | 1,459 | 69 (66–71) | 37 (33–40) |
| TCA | 1,279 | 55 (52–57) | 27 (23–32) |
| Anticonvulsant | 1,218 | 64 (61–66) | 35 (30–39) |
| Beta-blocker | 887 | 32 (29–35) | 14 (9–20) |
| SNRI | 881 | 66 (63–69) | 38 (33–43) |
a
Each medication class evaluated separately for patients initiating two classes
b
Calculated from the 93% of children with ≥60 days of continuous insurance in follow-up
c
98% of prescriptions were clonidine or guanfacine